News Archive 2018

Adelaide's historic link to X-ray discovery comes full circle

18 December 2018
In 2021, the first proton therapy unit in the southern hemisphere will open in Adelaide. The treatment will revolutionise cancer therapy in Australia, says UniSA Professor of Medical Radiation, Eva Bezak.

Breast screening vastly reduces risk of cancer death 

3 December 2018
Women who undertake regular breast screening checks have a 60 percent lower risk of dying from breast cancer withoin 10 years of diagnosis, new research shows

'Strongest evidence yet' that being obese causes depression

November 2018
New research has found the strongest evidence yet that obesity causes depression, even in the absence of other heath problems.

Outstanding UniSA research recognised through new awards

November 2018
The incredible and innovative work of more than 70 of UniSA’s researchers has been recognised and celebrated through the first event of its kind to be held at the University.  UniSA has introduced a new suite of University-wide Research Awards, which were presented as part of the inaugural UniSA Research Day in late October.

UniSA helping to bring cheaper, needle-free vaccines to the world

13 November 2018
In an international collaboration between Sementis and Enesi Pharma, Sementis Ltd is partnering up with the experts in the field of Zika virus and chikungunya vaccine research at UniSA’s Experimental Therapeutics Laboratory at its Cancer Research Institute to evaluate a needle-free vaccination technology developed by Enesi Pharma for Sementis’ SCV-based vaccines. 

Fighting obesity - could it be as plain as dirt?  UniSA research digs up the fat-fighting power of clays.

31 August 2018
Investigating how clay materials can improve drug delivery, UniSA researcher and PhD candidate, Tahnee Dening serendipitously discovered that the clay materials she was using had a unique ability to “soak up” fat droplets in the gut.

Pain and cancer experts to tackle survivor pain

20 August 2018
A renowned pain scientist at the University of South Australia, Professor Lorimer Moseley, is teaming up with cancer expert Professor Ian Olver to fast-track a long-awaited intervention for cancer survivors struggling with persistent pain. 

UniSA wins funding for research into cancer, aging, alcohol abuse and 3D bioprinting for medical use

13 August 2018
The University of South Australia has been awarded more than $2.6 million in the latest round of Federal Government funding to further research into Australia’s most critical health issues. 

Almost half of UniSA’s funding announced today from the National Health and Medical Research Council (NHMRC) has been awarded to find potential treatments for cancer, specifically brain tumours, acute myeloid leukaemia, bone marrow and head and neck cancers. 

My cancer is in remission - does this mean I'm cured? - Professor Ian Olver AM, Director, UniSA Cancer Research Institute

June 2018
So you’ve been through cancer treatment and your doctor has called you in for “some good news”. Satisfied, she tells you your cancer is “in remission”.

What does this mean? Are you cured? Is the cancer gone forever? And what about all those stories you’ve heard of someone who thought they’d “won the battle” – but then their cancer came back?

Research Australia Health and Medical Research Awards 2018 - Nominees announced

Congratulations goes to Professor Bill Runciman (HLS) who has been successful in making it to the final two nominees of the Health Services Research Award Category. This Award is for an individual who has provided leadership and made an outstanding contribution to health services research, has driven research that has led to a significant improvement in healthcare and/or has championed the development of the health services research field. Bill’s nomination was successful due to his extensive work in developing patient safety and standards for the discipline of Anaesthesia.

SAHMRI Annual Scientific Meeting Research Showcase - Pitch Perfect Award

Associate Professor Kristin Carson-Chahhoud (HLS) was recently awarded the Pitch Perfect Award at the Annual Scientific Meeting which took place on 25-26 October. The Research showcase took place on day 2 of the meeting. Congratulations Kristin on winning the much anticipated 'Pitch Perfect' award.

CSL Florey Next Generation Nominees

Following a University-wide selection process, both CSL Florey Next Generation nominees were selected from our Division. The 2018 CSL Florey Next Generation Award will shortly be conferred to a PhD candidate who has demonstrated outstanding capability, creativity and potential in the biomedical sciences and/or health and medical research.

Our good wishes go to Alexandra Wade (PhD candidate in HLS) and Hayley Schultz (PhD candidate in PMB) who submitted applications and a short (90 second) video that answered the question “What research challenge do I intend to solve during the course of my career”.  Alex took a creative approach and her video can be viewed here, whilst Hayley chose a more conventional approach which can be viewed here, both are exceptional nominees!

Beat Cancer - Travel Grant Success

Congratulations goes to Naranie Shanmuganathan, (PMB PhD candidate) for her success in theBeat Cancer Project Travel Grant. The Beat Cancer Project is a South Australian state-wide initiative intended to support and advance cancer research within the state. It is funded by Cancer Council SA and the SA Government (through SA Health) and administered by the South Australian Health and Medical Research Institute (SAHMRI).  Naranie received $2500 in the conference attendance and travel subcategory, which she will use towards attendance at the America Society of Haematology conference.

Success in the Controlled Release Asia (CRA) Meeting

A large delegation from PMB attended the Controlled Release Asia (CRA) meeting in Singapore in September. Two PMB students Santhni Subramaniam (Honours) and Chelsea Thorne (PhD) were selected from a pool of 130 students and gave very impressive presentations; resulting in 1st and 3rd place respectively.  Congratulation on your terrific achievements; you can see Santhni’s particularly wide smile in receiving the 1st prize of registration for a future meeting in Valencia, Spain.

UniSA Ranks as Australia’s top university for income derived from industry partnerships

Congratulations to the enterprising spirit of UniSA’s dedicated and talented Health Science researchers and the team of people which support these partnerships to fruition. Their combined hard work has recently been reflected in the Times Higher Education 2018 rankings.

UniSA Professor Shudong Wang honoured at NHMRC awards

World renowned cancer researcher, UniSA Professor Shudong Wang, was honoured at the National Health and Medical Research Council's (NHMRC) annual Research Excellence Awards in Canberra on 27 June, winning the Top Development Grant for 2017.

UniSA’s $247m Cancer Research Institute opens - an epicentre for cancer and aligned research

The $247 million, 14-storey UniSA Cancer Research Institute will open its doors today adding research, development and teaching capacity to South Australia in its war against cancer and a range of other diseases.

UniSA and Qianhong-LeSun Pharma Group’s new Sino-Australian joint laboratory to fast track new cancer drugs

The University of South Australia and China's Qianhong-LeSun Pharma group have joined forces to establish a multi-million dollar Sino-Australian Joint Laboratory in Innovative Drug Discovery to fast track the development of new treatments for cancer.

Improving treatment outcomes of heads and neck cancers

The involvement of a Human Papilloma Virus (HPV) results in head and neck cancer (HNC) with specific biological characteristics. Observations show HPV positive cancers exhibit increased chemo and radiation sensitivity and a UniSA research team has received a generous donation to investigate how this connection can benefit patients.

Easing the painful experience of oesophageal cancers

Professor Sanjay Garg and his team in the Centre for Pharmaceutical Innovation and Development (CPID) are developing new drug delivery technologies to improve the quality of life of terminally ill oesophageal cancer patients.

Crowdfunding campaign – Reducing Pain for Cancer Survivors

Help us develop an online tool that incorporates the latest in pain science and cancer research to help cancer survivors manage persistent pain after treatment. Donate today.